Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)

This study has been completed.
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Information provided by:
VA Office of Research and Development Identifier:
First received: April 5, 2002
Last updated: January 20, 2009
Last verified: November 2006